A Newcastle research team has been exploring the role of vitamin A in the pathogenesis of psychiatric disorders.
Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028 – Biotech Investments
PolyPeptide Group / Key word(s): Half Year Results 13-Aug-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer